A plummet in the company’s valuation and a recent board resignation have raised questions about the future of genetic data ...
The once-hot Silicon Valley startup has seen its stock’s value decline 99% and is struggling to survive. That has put the ...
23andMe is in trouble. Once a hot Silicon Valley startup, the genetic testing company has been in free fall since a major ...
DNA might contain health information, but unlike a doctor’s office, 23andMe is not bound by the health-privacy law HIPAA. And ...
DNA submitted by users to the genealogy company 23andMe will remain private for now, with CEO Anne Wojcicki saying she no ...
A law firm representing about 5,000 23andMe customers who demanded arbitration after hackers obtained sensitive data from the ...
Last year, 23andMe Holding Co. (NASDAQ:ME) said the company learned that a threat actor accessed several individual ...
With all seven independent directors resigning from 23andMe millions of customers are questioning how the company plans to ...
The board of directors for 23andMe quit following disagreements over the CEO's plans to privatize the DNA testing company.
Customers of genetic data outfit 23andMe may be at greater risk than they realize, suggests a New York Times story that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback